Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine in Malian Children
NCT04940130Phase 2Completed
- Sponsor
- Sanaria Inc.
- Start
- Apr 2022
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Sanaria PfSPZ Vaccine in Plasmodium falciparum malaria, sponsored by Sanaria Inc.. Started Apr 2022; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04940130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940130.